Amarin | AMRN - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
AbbVie USD 12.77B 132M 2025-09
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 127.31M 8.18M 2025-09
AstraZeneca USD 19.05B 1.49B 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
DBV Technologies USD 15.97M 279K 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Nektar Therapeutics USD 0 2.9M 2024-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 8.98B 192M 2025-09